Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term No discrete molecular pharmacological target is a classification used in pharmacological databases, such as ChEMBL, to describe therapeutic agents that do not exert their effects by binding to a specific biological macromolecule like a receptor, enzyme, or ion channel (Gaulton et al., 2012, Nucleic Acids Research). Instead, these substances work through broad physical or chemical mechanisms within the body. Common examples include antacids that neutralize gastric acid through direct chemical reactions and osmotic laxatives that alter the water content of the stool by creating an osmotic gradient (Goodman & Gilman's The Pharmacological Basis of Therapeutics). Other agents in this category include chelators that sequester metal ions and adsorbents like activated charcoal that physically bind toxins to prevent their absorption (StatPearls, 2023). Because these agents lack a high-affinity molecular binding site, they are often administered in gram quantities and exhibit non-specific pharmacodynamics. This classification is vital for biotech analysts to identify compounds that modify the physiological environment through bulk properties rather than targeted molecular signaling.
Drugs in this category act through physical or chemical processes such as acid-base neutralization, osmotic gradient shifts, sequestration of ions, or physical adsorption of molecules rather than binding to a specific protein target.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on No discrete molecular pharmacological target.